What FDA testing actually found about online peptides
A plain-language read of the FDA's market surveillance data — what was contaminated, what was underdosed, and what to look for on a label.
Read →Physician-supervised. U.S.-compounded. Third-party tested on every batch. And we'll tell you upfront if it's not right for you.
If you've done GLP-1s, you already know how this works. Same model, different molecules.

“FDA testing found 40% of peptides sold by research-chemical vendors had inaccurate dosing, contamination, or degradation. Ours don't.”
Every batch is assayed for actual peptide content against label claim. No assumptions.
Compounded by 503A and 503B pharmacies under USP <797> sterile conditions, with each lot screened before release.
Independent labs confirm identity, purity, and stability. We publish certificates of analysis on request.
Peptide research is uneven. On every peptide page, we mark evidence quality and call out where the data thins out.
Read the peptide library →Contraindications go above benefits — not buried in fine print. If a peptide isn't right for you, we'd rather you find out now.
See contraindications →Our clinical team's interaction notes are public, not paywalled behind an intake form. Bring them to your prescriber.
Read interaction guidance →For 40–55 year olds who want better sleep, more energy, and improved body composition. Our most common starting point.
A fuller endocrine optimization stack for active 35–50 year olds.
For 35–55 year olds focused on energy, mental clarity, and cellular repair. Popular with executives and biohackers — and people who've already tried GLP-1s and want what's next.
Two minutes. Health history, goals, current medications. No account required to find out if you qualify.
A licensed U.S. physician reviews your intake and meets you over video to discuss what's appropriate.
Baseline labs at a local draw site. If cleared, your prescription ships from a vetted compounding pharmacy.
Quarterly check-ins and repeat labs. We adjust the protocol — or stop it — based on what your body actually does.
A plain-language read of the FDA's market surveillance data — what was contaminated, what was underdosed, and what to look for on a label.
Read →Many of our patients arrive after semaglutide or tirzepatide. We walk through the most common next steps — and the ones we'd push back on.
Read →Active cancer. Pregnancy. Certain endocrine conditions. We'd rather lose a sale than ship the wrong protocol to the wrong person.
Read →The quiz takes 2 minutes. If you don't qualify, we'll tell you that too.